Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club
Ann Emerg Med
.
2020 Jan;75(1):116-118.
doi: 10.1016/j.annemergmed.2019.11.010.
Authors
William B Stubblefield
1
,
D Mark Courtney
2
,
Wesley H Self
1
Affiliations
1
Vanderbilt University Medical Center, Nashville, TN.
2
UT Southwestern Medical Center, Dallas, TX.
PMID:
31866020
DOI:
10.1016/j.annemergmed.2019.11.010
No abstract available